Sorrento Therapeutics Inc (NASDAQ:SRNE)

6.30
Delayed Data
As of Apr 20
 +0.10 / +1.61%
Today’s Change
1.50
Today|||52-Week Range
10.65
+65.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues3.8M4.6M8.2M151.9M
 
 
 
 
 
Cost of Goods Sold1.2M737.0K811.0K3.9M
 
 
 
 
 
Depreciation And Amortization3.2M2.4M2.9M7.1M
 
 
 
 
 
 
Operating ExpensesGross Income-563.0K1.5M4.5M140.8M
 
 
 
 
 
General Expenses34.0M51.5M64.4M88.5M
 
 
 
 
 
Research And Development24.0M31.3M42.2M55.5M
 
 
 
 
 
Total Operating Expenses38.4M54.6M68.1M99.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-34.5M-50.0M-59.9M52.3M
 
 
 
 
 
Extraordinary Credit0.000.0013.6M0.00
 
 
Extraordinary Charge-209.0K-27.4M-45.2M-31.3M
 
 
 
 
 
Pre-Tax Equity Earnings---4.0M435.0K--
 
 
 
Interest Expense On Debt1.6M1.7M1.6M5.0M
 
 
 
 
 
Equity In Earnings-------40.2M
 
 
Other Expenses0.0069.3M27.5M-1.0M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-36.4M-13.8M-64.8M15.3M
 
 
 
 
 
Income Taxes-1.7M-36.3M-896.0K-36.0M
 
 
 
 
 
Minority Interest0.00-4.3M-3.0M-2.0M
 
 
 
 
Net Income-34.7M-45.8M-60.9M9.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS26.7M36.9M50.4M69.7M
 
 
 
 
 
Shares To Calculate EPS Diluted26.7M36.9M50.4M70.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.30-$1.24-$1.21$0.13
 
 
 
 
 
EPS Diluted-$1.30-$1.24-$1.21$0.13